Fabry disease is a rare X-linked inherited disorder in which there is deficiency of α-galactosidase A (an enzyme in the glycosphingolipid pathway) that leads to progressive deposit of globotriaosylceramide (Gb3) in lysosomes. This disorder may present as CKD in young adulthood. Other associated clinical features include [...].
Answer
premature coronary artery disease, severe neuropathic pain, telangiectasias, and angiokeratomas
Question
Fabry disease is a rare X-linked inherited disorder in which there is deficiency of α-galactosidase A (an enzyme in the glycosphingolipid pathway) that leads to progressive deposit of globotriaosylceramide (Gb3) in lysosomes. This disorder may present as CKD in young adulthood. Other associated clinical features include [...].
Answer
?
Question
Fabry disease is a rare X-linked inherited disorder in which there is deficiency of α-galactosidase A (an enzyme in the glycosphingolipid pathway) that leads to progressive deposit of globotriaosylceramide (Gb3) in lysosomes. This disorder may present as CKD in young adulthood. Other associated clinical features include [...].
Answer
premature coronary artery disease, severe neuropathic pain, telangiectasias, and angiokeratomas
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it (an enzyme in the glycosphingolipid pathway) that leads to progressive deposit of globotriaosylceramide (Gb3) in lysosomes. This disorder may present as CKD in young adulthood. Other associated clinical features include <span>premature coronary artery disease, severe neuropathic pain, telangiectasias, and angiokeratomas.<span><body><html>
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p3388
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.